At ASHG in Boston, Eric Green received the society's Leadership Award and delivered an acceptance speech that moved the entire room.

Researchers now know that MS starts way earlier than the clinical onset, creating the real possibility that MS could one day be controlled.

Study findings suggest using the drug PF-06409577 to restore CDX2 in colon cancers could cut risk of recurrence and death by up to 50%.

Genomics unveils Mystra at ASHG 2025—an AI genetics platform to accelerate drug discovery and clinical validation using large-scale genetic data.

BioAgilytix now operates 355,000-square-feet of laboratory facilities, including 24,000-square-feet dedicated to LC/MS.

Researchers say findings help to bridge the structure of the genome to its function in managing how genes are turned on and off.

Preclinical study showed PDIA1 and PDIA5 protect cells from oxidative stress, maintain mitochondrial function, and are ...

Faulty brain circuits seen in Down syndrome may be caused by the lack of a particular molecule essential for the development and function of the nervous system, according to a new ...

Using CRISPR-based genetic engineering, the team further identified mutations in viral genes that prevent activation, ...

The peptide lab is designed to produce a range of molecules, including linear peptides, cyclic peptides, and peptide-drug conjugates.

Serbia’s BIO4 Campus reflects the convergence biosciences, AI, and IT to power innovation and global collaboration.

In this GEN webinar, a distinguished panel of experts discuss next-generation expression systems, optimized screening methods, and integrated development strategies that are enabling higher-performing ...